Sign in
4

Changes in Ownership

ARROWHEAD PHARMACEUTICALS, INC. Filed Acc 0001209191-17-001607

Chief Financial Officer acquired 145,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
Myszkowski Kenneth Allen Chief Financial Officer 2017-01-01 Grant or award +145,000 260,689 D
Loading xslF345X03/doc4.xml…